Marc Fater, MD
Plastic Surgery · Hyannis, MANPI 1467546804
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Sientra, Inc. at 23.6% of the total. Reporting peaked in 2022 at $368 and has fallen 68.5% since, to $116 in 2025.
Across 50 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$281
- Revance Therapeutics, Inc.$241
- Galderma Laboratories, L.p.$162
- Merz North America, Inc.$152
- Musculoskeletal Transplant Foundation Inc.$134
- AbbVie$129
- plus $92 from 1 others
What the payments were for
- Travel & lodging$111%
- Food & beverage$1,18099%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 4 | $281 |
| Revance Therapeutics, Inc. | 8 | $241 |
| Galderma Laboratories, L.p. | 9 | $162 |
| Merz North America, Inc. | 9 | $152 |
| Musculoskeletal Transplant Foundation Inc. | 7 | $134 |
| AbbVie(2 entities) | 8 | $129 |
| Mentor Worldwide LLC | 5 | $92 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,191 in reported general payments places this provider in the 60th percentile of 113 plastic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 50 | $306 |
| Scopolamine | 19 | $254 |
| Ondansetron OdtOndansetron | 27 | $94 |
| Oxycodone Hcl | 28 | $79 |
| Methylprednisolone | 12 | $74 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Hyannis
- Michael LoffredoHyannis$11K
- Seth JonesHyannis$7K
- William AustenBoston$150K
- Daniel DelvecchioBoston$141K
- Edward KobraeiBoston$78K
- Samuel LinBoston$72K
- Michael TantilloChestnut Hill$71K
- Katherine CarruthersBoston$55K
- Vickram TandonJamaica Plain$51K
- Sean DohertyBrookline$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.